| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 415 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 409 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 275 | 2024 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 268 | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 178 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 82 | 2024 |
| Bio-oriented synthesis of novel (S)-flurbiprofen clubbed hydrazone schiff’s bases for diabetic management: In vitro and in silico studies A Alam, M Ali, NU Rehman, S Ullah, SA Halim, A Latif, Zainab, A Khan, ... Pharmaceuticals 15 (6), 672, 2022 | 61 | 2022 |
| Novel Bis-Schiff’s base derivatives of 4-nitroacetophenone as potent α-glucosidase agents: Design, synthesis and in silico approach A Alam, M Ali, A Latif, NU Rehman, S Saher, A Khan, S Ullah, O Ullah, ... Bioorganic chemistry 128, 106058, 2022 | 51 | 2022 |
| Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies N Kausar, S Ullah, MA Khan, H Zafar, MI Choudhary, S Yousuf Bioorganic chemistry 106, 104499, 2021 | 39 | 2021 |
| Bio-oriented synthesis of novel polyhydroquinoline derivatives as α-glucosidase inhibitor for management of diabetes F Talab, S Ullah, A Alam, SA Halim, NU Rehman, Zainab, M Ali, A Latif, ... ACS omega 8 (7), 6234-6243, 2023 | 34 | 2023 |
| Synthesis, crystal structure and Hirshfeld Surface analysis of benzamide derivatives of thiourea as potent inhibitors of α-glucosidase in-vitro S Akhter, S Ullah, S Yousuf, H Siddiqui, MI Choudhary Bioorganic chemistry 107, 104531, 2021 | 30 | 2021 |
| 2-Mercapto benzothiazole derivatives: As potential leads for the diabetic management S Ullah, S Mirza, U Salar, S Hussain, K Javaid, KM Khan, R Khalil, ... Medicinal Chemistry 16 (6), 826-840, 2020 | 28 | 2020 |
| GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach M Shah, W Murad, N Ur Rehman, S Mubin, JN Al-Sabahi, M Ahmad, ... Molecules 26 (24), 7676, 2021 | 27 | 2021 |
| Novel polyhydroquinoline Schiff’s base derivatives: synthesis, characterization, in vitro α-glucosidase inhibitory, and molecular docking studies N Shahab, D Kong, M Ali, A Alam, N Ur Rehman, S Ullah, Z Zainab, ... Research on Chemical Intermediates 49 (7), 3005-3028, 2023 | 26 | 2023 |
| Phenoxy pendant isatins as potent α-glucosidase inhibitors: reciprocal carbonyl⋯ carbonyl interactions, antiparallel π⋯ π stacking driven solid state self-assembly and … S Mehreen, M Zia, A Khan, J Hussain, S Ullah, MU Anwar, A Al-Harrasi, ... RSC advances 12 (32), 20919-20928, 2022 | 26 | 2022 |
| Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as α-glucosidase inhibitors R Basri, S Ullah, A Khan, SN Mali, O Abchir, S Chtita, A El-Gokha, ... Bioorganic Chemistry 139, 106739, 2023 | 25 | 2023 |
| Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure–activity relationship studies S Wali, S Ullah, MA Khan, S Hussain, M Shaikh, MI Choudhary Bioorganic chemistry 119, 105506, 2022 | 22 | 2022 |
| Synthesis of new bis (dimethylamino) benzophenone hydrazone for diabetic management: In-vitro and in-silico approach M Khan, G Ahad, A Alam, S Ullah, A Khan, U Salar, A Wadood, A Ajmal, ... Heliyon 10 (1), 2024 | 21 | 2024 |
| Identification of α-Glucosidase Inhibitors from Scutellaria edelbergii: ESI-LC-MS and Computational Approach M Shah, H Rahman, A Khan, S Bibi, O Ullah, S Ullah, N Ur Rehman, ... Molecules 27 (4), 1322, 2022 | 21 | 2022 |
| Novel Benzimidazole Derivatives as Effective Inhibitors of Prolyl Oligopeptidase: Synthesis, in Vitro and in Silico Analysis A Shakoor, A Alam, F Jan, M Khan, M Ali, S Ullah, A Khan, AF AlAsmari, ... Future Medicinal Chemistry 16 (1), 43-58, 2024 | 19 | 2024 |
Ahmed Al-HarrasiChair of Natural & Medical Sciences Research Center, University of Nizwaunizwa.edu.om의 이메일 확인됨